在安全限值以下,每单位肾小球滤过率都重要:评估肾癌肾功能与肿瘤特异性死亡率的关系
该回顾性研究纳入1990至2015年间接受根治性或部分肾切除术的3457例cT1-2期肾细胞癌患者,采用竞争风险框架分析估算肾小球滤过率(eGFR)与肿瘤特异性死亡率(CSM)的关系。研究发现eGFR与CSM呈线性样条关系,仅在eGFR低于特定切点(65、85、60、65ml/min)时,eGFR降低与CSM升高相关。结论提示保留肾功能可能改善肿瘤相关生存。
要点
- eGFR与CSM的关系呈分段线性,切点在不同分析中为65、85、60、65ml/min。
- 仅当eGFR低于切点时,每降低10ml/min,CSM风险显著增加。
- 保留肾功能可能改善肾癌术后肿瘤相关生存。
核心结论
- 在因肾细胞癌接受手术的患者中,应保留肾功能以改善肿瘤相关生存。
研究设计与样本
- 回顾性分析3457例1990至2015年间因cT1-2期肾细胞癌行根治性(39%)或部分肾切除术(61%)的患者。
- eGFR采用CKD-EPI方程计算,CSM在多变量竞争风险框架中分析,估算考虑其他原因死亡的亚分布风险比(SHR)。
主要发现
- eGFR与CSM的关系由线性样条描述,时变协变量分析切点为65ml/min。
- 里程碑分析中基线、12个月和末次功能随访的eGFR切点分别为85、60和65ml/min。
- 多变量竞争风险分析中,仅eGFR低于上述切点时CSM与eGFR相关,每降低10ml/min的SHR分别为1.25(p=0.003)、1.16(p=0.028)、1.44(p=0.02)和1.16(p=0.042)。
- 联合模型证实了上述结果。
关键数值与推荐
- 时变eGFR每降低10ml/min,CSM的SHR为1.25(p=0.003),适用于eGFR低于65ml/min时。
- 基线eGFR每降低10ml/min,CSM的SHR为1.16(p=0.028),适用于eGFR低于85ml/min时。
- 12个月eGFR每降低10ml/min,CSM的SHR为1.44(p=0.02),适用于eGFR低于60ml/min时。
- 末次功能随访eGFR每降低10ml/min,CSM的SHR为1.16(p=0.042),适用于eGFR低于65ml/min时。
临床怎么用
- 肾癌手术决策中应重视保留肾功能,以可能改善肿瘤相关生存。
- 术后随访中eGFR低于相应切点时,需关注肿瘤特异性死亡风险增加。
局限性
- 回顾性设计存在数据收集固有的偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The hypothesis that renal function could influence oncological outcomes is supported by anecdotal literature. OBJECTIVE: To determine whether estimated glomerular filtration rate (eGFR) is related to cancer-specific mortality (CSM) in patients who had undergone surgery for renal cell carcinoma (RCC). DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis of 3457 patients who underwent radical (39%) or partial nephrectomy (61%) for cT1-2 RCC between 1990 and 2015. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The eGFR was calculated by the Chronic Kidney Disease Epidemiology Collaboration equation. CSM was analyzed in a multivariable competing-risk framework, estimating the subdistribution hazard ratio (SHR) accounting for deaths from other causes. The relationship between eGFR and CSM was investigated from multiple statistical approaches-extended Cox regression with eGFR incorporated as a time-dependent covariate, landmark analysis, and joint modeling. Other predictors were selected by competing-risk random forest method and backward elimination. RESULTS AND LIMITATIONS: The relationship between eGFR and CSM was graphically described by a linear spline, i.e. a continuous piecewise linear function with two lines joined by a knot. For eGFR treated as a time-dependent covariate, the knot was located at 65ml/min; at landmark analysis with eGFR at the baseline, 12 mo, and last functional follow-up, the knots were 85, 60, and 65ml/min, respectively. In multivariable competing-risk analysis, CSM was associated with eGFR only for values of eGFR below these cutoffs, with SHRs for every 10ml/min of reduction in eGFR of 1.25 (p=0.003), 1.16 (p=0.028), 1.44 (p=0.02), and 1.16 (p=0.042), corresponding to time-dependent eGFR, and eGFR at baseline, 12 mo, and last functional follow-up, respectively. Joint modeling confirmed these results. A retrospective design with inherent biases in data collection represents a limitation. CONCLUSIONS: In patients undergoing surgery for RCC, renal function should be preserved in order to improve cancer-related survival. PATIENT SUMMARY: The relationship between renal function and probability of dying due to renal cancer is complex. The present study found a correlation between glomerular filtration rate and cancer specific mortality that could reconsider the oncological role of renal function in patients undergoing surgery for renal cancer.
引用
- Antonelli A, Minervini A, Sandri M, et al. Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma. Eur Urol. 2018. PMID: 30104082. doi:10.1016/j.eururo.2018.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。